From left, Florenz Plassmann, Dean College of Arts & Sciences; Bob Colvin, Chair Biological Sciences; Tim Coleman; Jon Wang; and John Kopchick, Ph.D. mentor for both Tim and Jon.
By Kaitlyn Lyons
Researchers, scientists and educators from across the globe came together to give Ohio University students opportunities to network with professionals at “Careers & Entrepreneurship in the Sciences: Drugs, Devices, and Diagnostics” on Nov. 19.
Participants were able to experience career pathways through the perspectives of scientists, entrepreneurs and executives at the event co-hosted by Ohio University’s Center for Entrepreneurship, the College of Arts and Sciences Biological Sciences Department, and the university’s Corporate Engagement Office as part of Global Entrepreneurship Week.
This event focused on career as well as entrepreneurial possibilities throughout these sectors.
Well-known speakers included Patrick Connelly, chief executive officer at Pin Hill Ventures and senior Vertex Pharmaceuticals Fellow Emeritus. There were also two panels where audience members were given the opportunity to ask questions and hear about “insider” tips on how to succeed.
A panel on drug discovery included two Ohio University alumni who studied in the Molecular and Cellular Biology program: Dr. Xinzhong “Jon” Wang, chief scientific officer and senior vice president at CStone Pharmaceuticals, and Dr. Timothy Coleman, vice president of operations at Immunomic Therapeutics. Both Wang and Coleman were named this fall to the College of Arts & Sciences Notable Alumni.
- Notable Alumni | Jon Wang Pioneers Research in Oncology and Gene Therapy
- Notable Alumni | Timothy Coleman Tackles Health Issues from Allergies to Oncology
Wang earned a Ph.D. in Molecular and Cellular Biology from the College of Arts & Sciences at Ohio University in 1993. Coleman received his bachelor’s degree in Zoology from Rutgers-Newark, earned a Ph.D. in Molecular and Cellular Biology in 1991 from the College of Arts & Sciences at Ohio University, and completed his post-doctoral training in the lab of Dr. Craig Rosen at the Roche Institute of Molecular Biology.
The second panel was called “Entrepreneurship in Bioscience: No Cookie Cutter Approach.” This panel included Jon Snyder, the founder and executive adviser at Neuros Medical Inc.; Pam Groen, business leader and advisor at Global Biomedical; and Brad Lang, executive-in-residence at BioEnterprise.
Grown majored in Biological Science, pre-med, and Chemistry with a Mathematics minor in the College of Arts & Sciences at OHIO.
Comments